| SC 13D/A | 2014-12-04 | SOFINNOVA VENTURE PARTNERS VII L P | AERIE PHARMACEUTICALS INC | 916,657 | 3.8% | EDGAR |
| SC 13D/A | 2014-11-26 | TPG Group Holdings (SBS) Advisors, Inc. | AERIE PHARMACEUTICALS INC | 2,087,466 | 8.7% | EDGAR |
| SC 13D/A | 2014-07-18 | ACP IV, L.P. | AERIE PHARMACEUTICALS INC | 989,582 | 4.2% | EDGAR |
| SC 13D/A | 2014-07-11 | TPG Group Holdings (SBS) Advisors, Inc. | AERIE PHARMACEUTICALS INC | 3,387,466 | 14.5% | EDGAR |
| SC 13G/A | 2014-07-10 | WELLINGTON MANAGEMENT CO LLP | AERIE PHARMACEUTICALS INC | 2,459,199 | 10.5% | EDGAR |
| SC 13G | 2014-07-03 | Flynn James E | AERIE PHARMACEUTICALS INC | 1,417,508 | 6.0% | EDGAR |
| SC 13D/A | 2014-06-05 | SOFINNOVA VENTURE PARTNERS VII L P | AERIE PHARMACEUTICALS INC | 2,716,657 | 11.6% | EDGAR |
| SC 13D/A | 2014-05-30 | ACP IV, L.P. | AERIE PHARMACEUTICALS INC | 3,989,582 | 16.8% | EDGAR |
| SC 13G | 2014-02-14 | WELLINGTON MANAGEMENT CO LLP | AERIE PHARMACEUTICALS INC | 1,654,803 | 7.1% | EDGAR |
| SC 13D | 2013-11-12 | TPG Group Holdings (SBS) Advisors, Inc. | AERIE PHARMACEUTICALS INC | 4,387,466 | 19.8% | EDGAR |
| SC 13D | 2013-11-12 | ACP IV, L.P. | AERIE PHARMACEUTICALS INC | 4,289,582 | 19.3% | EDGAR |
| SC 13D | 2013-11-08 | SOFINNOVA VENTURE PARTNERS VII L P | AERIE PHARMACEUTICALS INC | 3,240,589 | 14.0% | EDGAR |
| SC 13D | 2013-11-04 | Clarus Lifesciences II, L.P. | AERIE PHARMACEUTICALS INC | 3,653,306 | 16.4% | EDGAR |